INSIGHTS ON PHARMA LOGISTICS

• Global Complexity Demands Local Resilience

  With integrated capabilities spanning early development through commercial manufacturing, our U.S. network helps customers build greater supply chain resilience, navigate uncertainty, and create a more reliable path to market.

• 3 Decision Domains Shaping Sterile Drug Product Success

  In sterile development, the decisions with the greatest downstream consequences are rarely recognized as such when they are made. Examine how these choices shape program outcomes across the lifecycle.

• Clinical Trial Logistics: What Biopharma Needs To Prepare For Next

  Fragmented clinical trial logistics are slowing programs and increasing risk. Learn how coordinated planning and digital visibility are becoming competitive advantages in complex, global studies.

• Accelerating Drug Development Through Integrated CDMO And CRO Partnership

  Coordinating drug substance, analytics, and clinical ops across multiple vendors puts you in the integrator role. See how connected CDMO-CRO partnerships eliminate that burden and reduce downstream risk.

• When Every Hour Counts: Emergency Transfer Protects Critical Biomedical Materials

  8/10/2026

  Rapid deployment of specialized cold chain logistics and cryogenic assets ensures strict temperature compliance, protecting critical research continuity and preventing catastrophic material loss.

• Flexibility In Drug Development: From Tactical Response To Strategic Discipline

  8/10/2026

  Historically managed through late-stage adjustments, operational adaptability has become a strategic imperative to prevent programs from stalling under real-world pressures.

• Distribution Automation System For Clinical Supply Chains

  7/15/2026

  Automated storage and retrieval technology reduces mis-picks, speeds order processing, and keeps clinical trial materials moving on time as study demands shift.

• Optimizing Clinical Supply Management With A One-Team Approach

  7/15/2026

  See how NewAmsterdam Pharma managed 11 global studies across 51 countries and 835 sites for 12,000+ patients without overwhelming their internal team.